Based in India, Ankit is a financial content writer and stock market
analyst. He has worked for almost a decade on several financial
projects related to the stock market news, fundamental research and
technical analysis for several websites. He obtained his Masters
Degree In finance (MS – finance) from ICFAI. Currently, he serves as
a financial consultant and technical analyst at Tradersinsights.com.
CLDR stock is showing severe selling pressure in Thursday’s trading session as Cloudera Inc (NYSE:CLDR) revealed Q1 results that missed analyst estimates, with revenue growth mainly driven by the Hortonworks acquisition. Additionally, the company announced …
PTI stock is moving higher in Tuesday’s session following the news that Proteostasis Therapeutics Inc (NASDAQ:PTI) received orphan drug designation in the EU for PTI-428, its treatment for cystic fibrosis.